These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34528314)

  • 1. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
    Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
    J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A; Babashah S; Garshasbi M
    J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Signature of Three microRNAs Is a Potential Diagnostic Biomarker for Glioblastoma.
    Hosein Yazdi A; Zarrinpour V; Moslemi E; Forghanifard MM
    Iran Biomed J; 2022 Jul; 26(4):301-12. PubMed ID: 35490305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
    Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
    Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study).
    Abak A; Amini S; Estiar MA; Montazeri V; Sakhinia E; Abhari A
    Clin Lab; 2018 Jan; 64(1):169-175. PubMed ID: 29479893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
    Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
    Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer.
    Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs signature on breast cancer: the MCC-Spain project.
    Gómez-Acebo I; Llorca J; Alonso-Molero J; Díaz-Martínez M; Pérez-Gómez B; Amiano P; Belmonte T; Molina AJ; Burgui R; Castaño-Vinyals G; Moreno V; Molina-Barceló A; Marcos-Gragera R; Kogevinas M; Pollán M; Dierssen-Sotos T
    Eur J Med Res; 2023 Nov; 28(1):480. PubMed ID: 37925534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer.
    Abd ELhafeez AS; Ghanem HM; Swellam M; Taha AM
    Cancer Biomark; 2024; 39(4):313-333. PubMed ID: 38250762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesis.
    Sharifi Z; Talkhabi M; Taleahmad S
    Sci Rep; 2022 Nov; 12(1):20135. PubMed ID: 36418345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and
    Ilkhani K; Delgir S; Safi A; Seif F; Samei A; Bastami M; Alivand MR
    Anticancer Agents Med Chem; 2021; 21(7):927-935. PubMed ID: 32972352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.